Dataset Information

Metabolomics of human primary B-ALL cells treated by BCR-Abl1 inhibitor, STI571, and p190 BCR-Abl+ BAF3 cells with ASS1 knockdown

ABSTRACT: Analyze the Metabolomics changes in B-ALL cells after the treatment of imatinib and p190+ BAF3 cells with ASS1 knockdown or left untreated. two methods as the below LC-MS description showed were used.

INSTRUMENT(S): Liquid Chromatography MS - alternating - reverse-phase

PROVIDER: MTBLS14638 | MetaboLights | 2026-07-08

REPOSITORIES: MetaboLights

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 34

			Action	DRS
	B-ALL-DMSO-1-carbon.raw	Raw
	B-ALL-DMSO-1-nitrogen.raw	Raw
	B-ALL-DMSO-2-carbon.raw	Raw
	B-ALL-DMSO-2-nitrogen.raw	Raw
	B-ALL-DMSO-3-carbon.raw	Raw

Dataset Information

Metabolomics of human primary B-ALL cells treated by BCR-Abl1 inhibitor, STI571, and p190 BCR-Abl+ BAF3 cells with ASS1 knockdown

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets